News About: Pharm. Industry
KFDA nods 14 items for clinical trials
The Korea Food and Drug Administration approved 14 clinical trials on 13 medicines and 1 medical device, between October 15-19.
The health watchdog said that it would make public such notice on a weekly basis in a ...
Drug makers to face tougher steps
The Financial Supervisory Commission (FSC) will soon announce results of its months-long investigation, as the agency has raised various suspicions including that some drug companies are providing rebates to hospitals...
Hyundai Pharm launches anticonvulsant agent for the treatment of epilepsy and bipolar disorderHyundai Pharm has recently introduced its anticonvulsant drug Lamogin (lamotrigine 100mg) used in the treatment of epilepsy and bipolar disorder.
For epilepsy it is used to t...
|
Samyang Genex opens new cGMP plant for injectablesSamyang Genex starts the operation of its newly established cGMP plant in Daejeon for production of injectables, such as Genexol injection, said a company spokesman on October 2...
|
U.S. Jennerex announces positive Phase I clinical results on JX-594
The U.S. Jennerex Biotherapeutics said on October 23 that its lead product candidate JX-594, a genetically-engineered vaccinia virus strain, demonstrated objective evidence of efficacy in 10 of the 13 evaluable Korean...
Wholesaler's concerns grow over new drug pricing policy
As drug price plunge and other negatives surrounding domestic pharmaceutical industry aren't likely to change in the near future, drug wholesalers are concerned about possible restructuring on the local market.
Owi...
Astellas's Vesicare insurance price plan hits snag
Astellas Pharma Korea wrapped its second round of Vesicare (solifenacin succinate) insurance price talks with the National Health Insurance Corporation without substantial progress.
Astellas proposed the insurance ...
Korea's seven researchers chosen for AstraZeneca's Virtual Research Institute project
AstraZeneca Korea (AZK) announced on October 23 it has finally chosen seven Korean researchers to conduct its Virtual Research Institute (VRI) after screening their papers, which was first launched last year in collab...
Mogam-Haus built on Aachen UniversityRWTH Aachen University, one of the most prestigious universities in Germany and one of the leading technology universities in Europe, announced on October 22 that it has constru...
|
Government mulls new price guideline over controversial drug policy
Amid rising concerns over two domestic drug makers' failure to get their drugs listed in the national health insurance scheme, Hyun Soo-yeop, director of Health Insurance Assessment Team in the Ministry of Health and ...
